Table 1.
Demographic and clinical characteristics of the sample.
| Overall Sample N=80 | PSQI Total < 5 (n=27) | PSQI Total ≥ 5 (n=53) | p | Sleep Efficiency ≥ 85%(n=41) | Sleep Efficiency < 85% (n=39) | p | |
|---|---|---|---|---|---|---|---|
|
| |||||||
| Age, M (SD) | 54.25 (7.94) | 52.23 (8.06) | 55.36 (7.73) | .11 | 52.10 (7.01) | 56.85 (8.31) | .01 |
|
| |||||||
| Months Since Diagnosis | |||||||
| M (SD) | 19.73 (10.44) | 20.19 (9.04) | 19.49 (11.19) | .79 | 20.27 (10.44) | 19.19 (10.55) | .66 |
| Median (range) | 18.31 (2.60-44.25) | 19.15 (4.08-37.55) | 16.80 (2.60-44.25) | 19.28 (2.60-44.25) | 16.54 (2.99-43.76) | ||
|
| |||||||
| Acculturation Score, M (SD) | 1.91 (0.54) | 1.98 (0.61) | 1.87 (0.52 | .41 | 1.93 (0.55) | 1.88 (0.55) | .70 |
|
| |||||||
| Annual Income | .19 | .74 | |||||
| <$45,000 | 55 (69%) | 18 (67%) | 37 (70%) | 29 (71%) | 26 (67%) | ||
| ≥$45,000 | 11 (14%) | 6 (22%) | 5 (9%) | 7 (17%) | 4 (10%) | ||
| Missing/Not reported | 14 (18%) | 3 (11%) | 11 (21%) | 5 (12%) | 9 (23%) | ||
|
| |||||||
| Education | .02 | .43 | |||||
| ≤Some college | 57 (71%) | 15 (56%) | 42 (79%) | 28 (68%) | 29 (74%) | ||
| ≥College graduate | 22 (28%) | 12 (44%) | 10 (19%) | 13 (32%) | 9 (23%) | ||
| Missing/Not reported | 1 (1%) | 0 (0%) | 1 (2%) | 0 (0%) | 1 (3%) | ||
|
| |||||||
| Marital Status | .20 | .92 | |||||
| Not Married | 23 (29%) | 22 (81%) | 35 (66%) | 12 (29%) | 11 (28%) | ||
| Married | 57 (71%) | 5 (19%) | 18 (34%) | 29 (71%) | 28 (72%) | ||
|
| |||||||
| Stage at diagnosis | .82 | .64 | |||||
| 0, I | 37 (46%) | 12 (44%) | 25 (47%) | 20 (49%) | 17 (44%) | ||
| II, III | 43 (54%) | 15 (56%) | 28 (53%) | 21 (51%) | 22 (56%) | ||
|
| |||||||
| Lumpectomy or mastectomy | .68 | .43 | |||||
| Not received | 7 (9%) | 3 (11%) | 4 (8%) | 5 (12%) | 2 (5%) | ||
| Received | 73 (91%) | 24 (89%) | 49 (92%) | 36 (88%) | 37 (95%) | ||
|
| |||||||
| Chemotherapy | .32 | .27 | |||||
| Not received | 32 (40%) | 13 (48%) | 19 (36%) | 19 (46%) | 13 (33%) | ||
| Received | 47 (59%) | 14 (52%) | 33 (62%) | 22 (54%) | 25 (64%) | ||
| Missing/Not reported | 1 (1%) | 0 (0%) | 1 (2%) | 0 (0%) | 1 (3%) | ||
|
| |||||||
| Radiotherapy | .88 | .66 | |||||
| Not received | 47 (59%) | 16 (59%) | 31 (58%) | 26 (63%) | 21 (54%) | ||
| Received | 28 (35%) | 10 (37%) | 18 (34%) | 14 (34%) | 14 (36%) | ||
| Missing/Not reported | 5 (6%) | 1 (4%) | 4 (8%) | 1 (2%) | 4 (10%) | ||
|
| |||||||
| Aromatase Inhibitors | .60 | .28 | |||||
| Not currently taking | 28 (35%) | 11 (41%) | 17 (32%) | 17 (41%) | 11 (28%) | ||
| Currently taking | 48 (60%) | 16 (59%) | 32 (60%) | 23 (56%) | 25 (64%) | ||
| Missing | 4 (5%) | 0 (0%) | 4 (8%) | 1 (2%) | 3 (8%) | ||
Note: PSQI=Pittsburgh Sleep Quality Index. M=mean. SD=standard deviation.